Company Profiles

driven by the PitchBook Platform

Lostam BioPharmaceuticals

2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of protein therapeutics. The company develops protein therapeutics to prevent and treat lethal Gram-negative bacterial infections associated primarily within the hospital setting.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
Nazareth Industrial Area
PO Box 2252
Nazareth 16000
Israel

+972 (0)4 609 8614
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lostam BioPharmaceuticals’s full profile, request a free trial.

Lostam BioPharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Lostam BioPharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0

Lostam BioPharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Lewis Neville Ph.D Founder, Chief Technology Officer & Chief Executive Officer